Issue 9/2005
Content (12 Articles)
Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy
Gregory B. Lesinski, Daniel Valentino, Erinn M. Hade, Susie Jones, Cynthia Magro, Abhik Ray Chaudhury, Michael J. Walker, William E. Carson III
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy
Tobias Krüger, Oliver Schoor, Claudia Lemmel, Bjoern Kraemer, Christian Reichle, Jörn Dengjel, Toni Weinschenk, Margret Müller, Jörg Hennenlotter, Arnulf Stenzl, Hans-Georg Rammensee, Stefan Stevanović
Role of tumor-derived transforming growth factor-β1 (TGF-β1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma
V. S. Thakur, B. Shankar, S. Chatterjee, S. Premachandran, K. B. Sainis
Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer
A. M. Waterston, L. Gumbrell, T. Bratt, S. Waller, J. Gustav-Aspland, C L‘Hermenier, K Bellenger, M Campbell, T Powles, M Highley, M Bower, S. Mouritsen, M. Feldmann, R. C. Coombes
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas
Jose Manuel Cózar, Julia Canton, Miguel Tallada, Angel Concha, Teresa Cabrera, Federico Garrido, Francisco Ruiz-Cabello Osuna
Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes
Kfir Oved, Avital Lev, Roy Noy, Dina Segal, Yoram Reiter
Exposure to the electrofusion process can increase the immunogenicity of human cells
Barry D. Hock, Georgina Roberts, Judith L. McKenzie, Prachee Gokhale, Nina Salm, Alexander D. McLellan, Nigel W. Patton, Justin A. Roake
Sustained low-level expression of interferon-γ promotes tumor development: potential insights in tumor prevention and tumor immunotherapy
Yu-Fei He, Xiao-Hong Wang, Gui-Mei Zhang, Hong-Tao Chen, Hui Zhang, Zuo-Hua Feng
Transforming growth factor-β1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system
Florian Weber, Scott N. Byrne, Shery Le, David A. Brown, Samuel N. Breit, Richard A. Scolyer, Gary M. Halliday
Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo
Jia-Hai Ma, Yan-Fang Sui, Jing Ye, Ya-Yu Huang, Zeng-Shan Li, Guang-Sheng Chen, Ping Qu, Hong-Ping Song, Xiu-Min Zhang
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
Janet M. D. Plate, Aileen E. Plate, Susan Shott, Susan Bograd, Jules E. Harris
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study
J. M. Kerst, A. Bex, H. Mallo, L. Dewit, J. B. A. G. Haanen, W. Boogerd, H. J. Teertstra, G. C. de Gast